Cannabinoids

Across generations, cannabinoids aid in physical recovery from exercise, survey finds

22-Sep-2023 By Claudia Adrien

CBD and/or THC users between 18-68 years old who avidly participate and are trained in aerobic and resistance exercise report the compounds aid in their physical recuperation, a new survey determined.

CBD in 2022: A year in review

06-Dec-2022 By Danielle Masterson

We’re five years in, so what does the CBD industry look like now and what can we expect in 2023? We spoke with several CBD experts who walked us through the highs and lows of 2022.

Vertosa, University of Massachusetts Amherst join forces to study CBG

11-Jul-2022 By Danielle Masterson

Researchers say there are more questions than answers surrounding the minor cannabinoid, so the partnership signifies a step in the right direction.

Parliamentary group divided on proposals for new CBD approval system

29-Jun-2022 By Nicola Gordon-Seymour

Proposals to overhaul the UK Cannabidiol (CBD) approval system has led to tension among some members of the Secretariat Advisory Board (SAB) of the All-Party Parliamentary Group (APPG) that liaises with government to inform industry policies.

UK government urged to become world leader in cannabinoid innovation

28-Jun-2022 By Kavitha Sivasubramaniam

The UK could become a world leader in cannabinoid innovation by following 20 key recommendations, according to a just-published report.

Study: Many CBD products would trigger doping bans

09-Jun-2022 By Shane Starling

Almost a third of 23 tested CBD products contained traces of banned cannabinoids at levels that would have provoked doping infringements, according to a just-published study.

UK’s FSA unveils list of permitted CBD products

01-Apr-2022 By Kavitha Sivasubramaniam

The UK’s Food Standards Agency (FSA) has released a list of cannabinoid (CBD) products which can be sold to consumers, becoming the first country globally to regulate the market for orally consumed, safe legal cannabis extracts.

Company demonstrates small commercial scale fermentation process for CBG, GBGA

10-Feb-2021 By Hank Schultz

A cannabinoid product developer has announced it has successfully demonstrated CBG and CBGA production from a proprietary fermentation process.

Startup claims fermentation expertise will provide differentiator in production of rare cannabinoids

02-Dec-2020 By Hank Schultz

A startup armed with years of university research is seeking to make a splash in the hemp space with a line of cannabinoids produced via fermentation.

Demetrix begins demo scale production of rare cannabinoid CBG

03-Sep-2020 By Elaine Watson

Demetrix – one of a new wave of biotech firms producing cannabinoids via biosynthesis (rather than extracting them from cannabis plants) – has commenced 15,000-liter demo-scale fermentation production of CBG (cannabigerol), the first rare cannabinoid...

Willow Biosciences to start pilot production of biosynthetic CBG in Q3

18-Aug-2020 By Stephen Daniells

Canada-based Willow Biosciences Inc. has announced it will soon start to deliver its first samples of “ultra-pure, pharmaceutical grade” cannabigerol (CBG) from its 500-liter pilot production run.

Weighing the risks of CBD in sports nutrition

20-May-2020 By Danielle Masterson

As cannabis legalization spreads across the country, professional sports leagues are updating their policies, while some players update their portfolios.

NutraCast Podcast: Patrick McCarthy on CBD research and regulation

17-Apr-2020 By Danielle Masterson

In recent months the FDA has been trying to figure out how to get the CBD market under control, with the focus on safety. Patrick McCarthy, CEO of Validcare, a cannabis sector-focused health and wellness research company, said the FDA is not going to...